Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Delayed Quote USD

Dermata Therapeutics, Inc. (DRMA)

Compare
0.9997
-0.0803
(-7.44%)
At close: April 1 at 4:00:01 PM EDT
1.0000
+0.00
+(0.03%)
After hours: April 1 at 7:59:56 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
12,513.2420
12,513.2420
8,041.9060
9,674.4860
7,856.8640
Operating Income
-12,513.2420
-12,513.2420
-8,041.9060
-9,674.4860
-7,856.8640
Net Non Operating Interest Income Expense
225.7810
225.7810
247.2160
63.5730
-45.6130
Pretax Income
-12,287.4610
-12,287.4610
-7,794.6900
-9,610.9130
-7,902.4770
Net Income Common Stockholders
-12,287.4610
-12,287.4610
-7,794.6900
-9,610.9130
-10,464.7140
Diluted NI Available to Com Stockholders
-12,287.4610
-12,287.4610
-7,794.6900
-9,610.9130
-10,464.7140
Basic EPS
-8.03
--
-39.99
-208.80
-583.20
Diluted EPS
-8.03
--
-39.99
-208.80
-583.20
Basic Average Shares
1,529.7720
--
194.9280
46.0440
17.9250
Diluted Average Shares
1,529.7720
--
194.9280
46.0440
17.9250
Total Operating Income as Reported
-12,513.2420
-12,513.2420
-8,041.9060
-9,674.4860
-7,856.8640
Total Expenses
12,513.2420
12,513.2420
8,041.9060
9,674.4860
7,856.8640
Net Income from Continuing & Discontinued Operation
-12,287.4610
-12,287.4610
-7,794.6900
-9,610.9130
-7,902.4770
Normalized Income
-12,287.4610
-12,287.4610
-7,794.6900
-9,610.9130
-7,902.4770
Interest Income
225.7810
225.7810
247.2160
63.5730
--
Interest Expense
--
--
--
-63.5730
45.6130
Net Interest Income
225.7810
225.7810
247.2160
63.5730
-45.6130
EBIT
-12,513.2420
-12,513.2420
-8,041.9060
-9,674.4860
-7,856.8640
EBITDA
-12,513.2420
-12,513.2420
-8,041.9060
-9,674.4860
-7,856.8640
Net Income from Continuing Operation Net Minority Interest
-12,287.4610
-12,287.4610
-7,794.6900
-9,610.9130
-7,902.4770
Normalized EBITDA
-12,513.2420
-12,513.2420
-8,041.9060
-9,674.4860
-7,856.8640
12/31/2021 - 8/13/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers